microdose glp-1 menopause Microdosing During Menopause: Is it Right for You? Microdosing for GLP-1s for Menopause-Related

My waistline is back to normal

PALO ALTO, Calif., September 28, 2023 (BUSINESS WIRE)-- Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced today the launch of its latest innovation in obesity care,Digbi GLP-Fit, a scientifically-backed approach to identify the best treatment path for an individual to prevent and treat obesity. Key Highlights: Digbi GLP-Fituses the science of precision biology to identify the best treatment path for obesity for an individual with 87% accuracy, which may include 1) only precision nutrition, 2) a combination of precision nutrition and lower-cost drugs like Metformin, or 3) a combination of precision nutrition and GLP-1 medications

This unique dual-action approach helps with managing appetite suppression, digestion time, and insulin levels

Sugar-free, non-GMO, gluten-free, and naturally flavored for daily use.

Key Mechanisms of Action : GLP-1 Receptor Agonism (Activation): Similar to current weight-loss drugs, it mimics the GLP-1 hormone to increase satiety (feeling full) and reduce appetite